Literature DB >> 18038270

Human tau protein forms complex with PrP and some GSS- and fCJD-related PrP mutants possess stronger binding activities with tau in vitro.

Xiao-Fan Wang1, Chen-Fang Dong, Jin Zhang, Yan-Zhen Wan, Feng Li, Yin-Xia Huang, Lu Han, Bing Shan, Chen Gao, Jun Han, Xiao-Ping Dong.   

Abstract

Microtubule associated protein tau is considered to play roles in some types of human transmissible spongiform encephalopathies (TSE). In this study, the full-length and several truncated human tau proteins were expressed from E. coli and purified. Using GST pull down, co-immunoprecipitation assay and tau-coated ELISA, the molecular interaction between tau protein and PrP was confirmed in the context of the full-length human tau. The N terminus (amino acids 1-91) and tandem repeats region (amino acids 186-283) of tau protein were responsible for the interaction with PrP. The octapeptide repeats within PrP directly affected the binding activity of PrP with tau. GSS-related mutant PrP102L and fCJD- related mutants with two and seven extra octarepeats showed more active binding capacity with tau than wild-type PrP. The molecular interactions between PrP and tau protein highlight a potential role of tau in the biological function of PrP and the pathogenesis of TSE.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18038270     DOI: 10.1007/s11010-007-9664-6

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  33 in total

1.  Polymorphism of the codon 129 of the prion protein (PrP) gene and neuropathology of cerebral ageing.

Authors:  Claudine Berr; Nicole Helbecque; Véronique Sazdovitch; Michel Mohr; Carole Amant; Philippe Amouyel; Annick Alpérovitch; Jean-Jacques Hauw
Journal:  Acta Neuropathol       Date:  2003-04-05       Impact factor: 17.088

2.  Physical and chemical properties of purified tau factor and the role of tau in microtubule assembly.

Authors:  D W Cleveland; S Y Hwo; M W Kirschner
Journal:  J Mol Biol       Date:  1977-10-25       Impact factor: 5.469

3.  Neuronal degeneration and neurofilament accumulation in the trigeminal ganglia in Creutzfeldt-Jakob disease.

Authors:  D C Guiroy; S K Shankar; C J Gibbs; J A Messenheimer; S Das; D C Gajdusek
Journal:  Ann Neurol       Date:  1989-01       Impact factor: 10.422

4.  The FTDP-17-linked mutation R406W abolishes the interaction of phosphorylated tau with microtubules.

Authors:  M Pérez; F Lim; M Arrasate; J Avila
Journal:  J Neurochem       Date:  2000-06       Impact factor: 5.372

5.  Abnormal patterns of microtubule-associated protein-2 (MAP-2) immunolabeling in neuronal nuclei and Lewy bodies in Parkinson's disease substantia nigra brain tissues.

Authors:  M R D'Andrea; S Ilyin; C R Plata-Salaman
Journal:  Neurosci Lett       Date:  2001-06-29       Impact factor: 3.046

6.  Altered toxicity of the prion protein peptide PrP106-126 carrying the Ala(117)-->Val mutation.

Authors:  D R Brown
Journal:  Biochem J       Date:  2000-03-15       Impact factor: 3.857

7.  Regulation of tau exon 10 splicing by a double stem-loop structure in mouse intron 10.

Authors:  Takenari Yamashita; Takami Tomiyama; Qiang Li; Hideharu Numata; Hiroshi Mori
Journal:  FEBS Lett       Date:  2005-01-03       Impact factor: 4.124

8.  Hyperphosphorylated tau deposition parallels prion protein burden in a case of Gerstmann-Sträussler-Scheinker syndrome P102L mutation complicated with dementia.

Authors:  Keisuke Ishizawa; Takashi Komori; Tomokazu Shimazu; Toshimasa Yamamoto; Tetsuyuki Kitamoto; Kunio Shimazu; Takanori Hirose
Journal:  Acta Neuropathol       Date:  2002-05-14       Impact factor: 17.088

9.  Progressive supranuclear palsy: extensive neuropil threads in addition to neurofibrillary tangles. Very similar antigenicity of subcortical neuronal pathology in progressive supranuclear palsy and Alzheimer's disease.

Authors:  A Probst; D Langui; C Lautenschlager; J Ulrich; J P Brion; B H Anderton
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

Review 10.  Cell death mechanisms in neurodegeneration.

Authors:  K A Jellinger
Journal:  J Cell Mol Med       Date:  2001 Jan-Mar       Impact factor: 5.310

View more
  26 in total

1.  Alzheimer's disease: A prion protein connection.

Authors:  Moustapha Cisse; Lennart Mucke
Journal:  Nature       Date:  2009-02-26       Impact factor: 49.962

2.  Molecular interaction of α-synuclein with tubulin influences on the polymerization of microtubule in vitro and structure of microtubule in cells.

Authors:  R M Zhou; Y X Huang; X L Li; C Chen; Q Shi; G R Wang; C Tian; Z Y Wang; Y Y Jing; C Gao; X P Dong
Journal:  Mol Biol Rep       Date:  2009-10-14       Impact factor: 2.316

3.  Complex proteinopathy with accumulations of prion protein, hyperphosphorylated tau, α-synuclein and ubiquitin in experimental bovine spongiform encephalopathy of monkeys.

Authors:  Pedro Piccardo; Juraj Cervenak; Ming Bu; Lindsay Miller; David M Asher
Journal:  J Gen Virol       Date:  2014-04-25       Impact factor: 3.891

4.  Dysfunction of microtubule-associated proteins of MAP2/tau family in Prion disease.

Authors:  Jin Zhang; Xiao-Ping Dong
Journal:  Prion       Date:  2012-08-09       Impact factor: 3.931

Review 5.  Is synaptic loss a unique hallmark of Alzheimer's disease?

Authors:  Stephen W Scheff; Janna H Neltner; Peter T Nelson
Journal:  Biochem Pharmacol       Date:  2014-01-09       Impact factor: 5.858

Review 6.  Amyloidogenesis of Tau protein.

Authors:  Bartosz Nizynski; Wojciech Dzwolak; Krzysztof Nieznanski
Journal:  Protein Sci       Date:  2017-09-13       Impact factor: 6.725

7.  Context dependent neuroprotective properties of prion protein (PrP).

Authors:  Andrew D Steele; Zhipeng Zhou; Walker S Jackson; Chunni Zhu; Pavan Auluck; Michael A Moskowitz; Marie-Francoise Chesselet; Susan Lindquist
Journal:  Prion       Date:  2009-10-16       Impact factor: 3.931

8.  Cellular Prion Protein Mediates the Disruption of Hippocampal Synaptic Plasticity by Soluble Tau In Vivo.

Authors:  Tomas Ondrejcak; Igor Klyubin; Grant T Corbett; Graham Fraser; Wei Hong; Alexandra J Mably; Matthew Gardener; Jayne Hammersley; Michael S Perkinton; Andrew Billinton; Dominic M Walsh; Michael J Rowan
Journal:  J Neurosci       Date:  2018-10-24       Impact factor: 6.167

9.  Role of PrP(C) Expression in Tau Protein Levels and Phosphorylation in Alzheimer's Disease Evolution.

Authors:  C Vergara; L Ordóñez-Gutiérrez; F Wandosell; I Ferrer; J A del Río; R Gavín
Journal:  Mol Neurobiol       Date:  2014-06-26       Impact factor: 5.590

10.  PrP octarepeats region determined the interaction with caveolin-1 and phosphorylation of caveolin-1 and Fyn.

Authors:  Qi Shi; Yuan-Yuan Jing; Shao-Bin Wang; Cao Chen; Han Sun; Yin Xu; Chen Gao; Jin Zhang; Chan Tian; Yan Guo; Ke Ren; Xiao-Ping Dong
Journal:  Med Microbiol Immunol       Date:  2013-01-03       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.